Vantage logo

Bluebird split looks premature

Today’s safety scare with Lentiglobin calls into question the logic behind Bluebird’s planned business separation.

Vantage logo

Bayer’s gene therapy juggling act

Two arm’s-length acquisitions and two licensing deals have given Bayer a cell and gene therapy unit; now to bring it all together.